Catalent Inc.

In News

Catalent and Elpida Therapeutics Join Forces for Gene Therapy Scale-Up - CHEManager

CHEManager - May 20, 2026

Catalent and Elpida Therapeutics Enter Strategic Partnership for Late-Phase AAV Manufacturing - Business Wire

Business Wire - May 13, 2026

Catalent Agrees To Pay $78M To Settle Securities Suit - Law360

Law360 - May 08, 2026

Catalent $78M Securities Class Class Action Settlement - Claim Depot

Claim Depot - Jan 20, 2026

Catalent lays off 350 workers in Maryland after 'large customer' dials back orders - Fierce Pharma

Fierce Pharma - Aug 20, 2025

Catalent and GelMEDIX Enter Global Partnership for the Development and Clinical Manufacturing of iPSC-Derived Cell Therapies in Ocular and Retinal Diseases - BioSpace

BioSpace - Mar 11, 2026

Inspection issues remain at Catalent Indiana plant, pharma companies say - Inside INdiana Business

Inside INdiana Business - Mar 10, 2026

Drug manufacturer cuts 96 jobs in third round of layoffs - The Business Journals

The Business Journals - Feb 20, 2026

Pharmaceutical manufacturer Catalent to lay off nearly 350 Maryland employees - CBS News

CBS News - Aug 22, 2025

Catalent Unveils New Brand Amid Strategic Shift and Global Expansion - Contract Pharma

Contract Pharma - Oct 28, 2025

Cartherics and Catalent Expand Commercial License Agreement - Business Wire

Business Wire - Apr 09, 2026

FDA rejects Scholar Rock's SMA drug, citing issues at Novo's Catalent Indiana site - Fierce Pharma

Fierce Pharma - Sep 23, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment